Stockreport

KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan [Yahoo! Finance]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF -Kaken brings regional expertise and proven track record in commercializing innovative therapies- CAMBRIDGE, Mass. & SALISBURY, England, April 08, 2025 BUSINESS WIRE [Read more]